Sign in / Join Now
ETFs & Funds
: Wall St completely ignoring great results of ALS and
should just buy them out. Ridiculously undervalued at $70M
Omecamtiv is a wonder drug that can be used in the ICU like water. It raises
. Too good to be true.
As a long-time ICU nurse who's seen tons of tachyarrythmia from inotropes, I agree (seems too good to be true). Interesting.
Add a reply...
Latest StockTalks »
people get CYTK breaking news and analysis by email alert.
Get email alerts on CYTK »
Get latest price
From other sites
Cytokinetics (CYTK) Looks Good: Stock Adds 6.8% in Session
at Zacks.com (Jun 16, 2016)
Should You Buy Cytokinetics (CYTK) Ahead of Earnings?
at Zacks.com (Feb 12, 2016)
Cytokinetics (CYTK) Looks Good: Stock Moves 8.8% Higher
at Zacks.com (Dec 3, 2015)
Can Cytokinetics (CYTK) Run Higher on Strong Earnings Estimate Revisions?
at Zacks.com (Nov 23, 2015)
Cytokinetics (CYTK) Shares March Higher, Can It Continue?
at Zacks.com (Nov 18, 2015)